Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

30.8%

4 terminated/withdrawn out of 13 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

83%

5 of 6 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

N/A
13(100.0%)
13Total
N/A(13)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)